slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 89,491-89,520
Pages 3,683
Rows per page 30
Component
89,491-89,520 of 110,471
06
Bausch Health Companies | Results Presentation Deck | 48 slidesBausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · Attention1 hit
07
Unconsolidated revenue change vs 2Q22, in millions USD. Includes non-GAAP organic growth metrics.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · Attention1 hit
11
Includes revenue figures in millions USD and percentage growth metrics.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
12
The slide uses a 2x2 grid layout to present segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
13
Includes reported vs organic growth metrics and segment-specific revenue drivers.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
21
The slide uses stacked bar charts to represent the split between B+L and BHC (excl. B+L) segments.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
29
The slide uses a 2x2 grid layout to present segment-specific revenue and prescription growth data.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
14
Benson Hill | Results Presentation Deck | 30 slidesBenson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
20
Includes adjustments for 'Open Mark-to-Market Timing differences' and excludes 'Fresh Business'.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · Financials1 hit
21
The slide presents a financial bridge/reconciliation of guidance metrics.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · Financials1 hit
06
The slide combines a list of value propositions with a testimonial box.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
08
The slide uses a horizontal arrow-based layout to categorize offerings.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Solution1 hit
09
The slide highlights two core product offerings and lists key capabilities and representative customers (L3Harris and US Navy).Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Solution1 hit
11
The slide uses a numbered list to detail specific contract outcomes and competitive wins.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
12
Bigbear AI | Investor Presentation Deck | 29 slidesBigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Competition1 hit
19
Includes non-GAAP measure disclosure.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Financials1 hit
24
Bigbear AI | Investor Presentation Deck | 29 slidesBigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
25
Includes a process diagram showing inputs (models, schedules, ERP), constraints, and outputs (maps, timelines, charts).Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
06
The slide uses a visual comparison between healthy cells (alkaline) and cancer cells (acidic) to demonstrate the selective binding mechanism.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
11
The slide uses a waterfall plot for response and a spider plot for longitudinal tumor burden change.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
13
Includes clinical trial design details (dosing regimens, patient counts, endpoints).BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
15
Includes specific clinical trial data (N=73 and N=26) and detailed breakdown of specific adverse events like constipation, neuropathy, and diarrhea.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
17
The chart is a classic waterfall plot used in oncology to show tumor shrinkage/growth.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Traction1 hit
21
Includes specific clinical trial safety metrics and footnotes regarding data definitions.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
25
The slide uses a combination of high-level market statistics and specific clinical benchmarks to define the target opportunity.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
26
The chart highlights a specific patient case with a partial response (PR) and notes a suboptimal dose case.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
27
Uses a 2x2 grid of metrics to frame the problem space.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
29
The slide uses a funnel-like logic to narrow down from total prevalence to a specific addressable patient population for a 2L+ therapy.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
39
The slide uses a process flow diagram to illustrate dose escalation strategies (Accelerated vs Standard vs Priming).BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
14
Includes specific financial targets related to rebates, cash consideration, and seller notes.Blue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations 1 hit